Clinical Trial Update: Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant low-dose radiotherapy combined with anti-PD-1 immunotherapy for resectable locally advanced head and neck squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Anti-PD-1 immunotherapy

Snippet

Sponsor: Xiwei XU | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING